Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Helius Medical Technologies, Inc is a medical devices business based in the US. Helius Medical Technologies shares (HSDT) are listed on the NASDAQ and all prices are listed in US Dollars. Helius Medical Technologies employs 19 staff and has a trailing 12-month revenue of around USD$622,000.
|Latest market close||USD$15.49|
|52-week range||USD$0.249 - USD$1.47|
|50-day moving average||USD$0.4019|
|200-day moving average||USD$0.4455|
|Wall St. target price||USD$2.12|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.341|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||-4.97%|
|1 month (2020-12-15)||3,713.39%|
|3 months (2020-10-15)||3,502.33%|
|6 months (2020-07-15)||2,897.29%|
|1 year (2020-01-15)||1,389.42%|
|2 years (2019-01-15)||85.51%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||1,843.54%|
|Gross profit TTM||USD$650,000|
|Return on assets TTM||-110.59%|
|Return on equity TTM||-281.65%|
|Market capitalisation||USD$21 million|
TTM: trailing 12 months
There are currently 889,285 Helius Medical Technologies shares held short by investors – that's known as Helius Medical Technologies's "short interest". This figure is 0% up from 888,932 last month.
There are a few different ways that this level of interest in shorting Helius Medical Technologies shares can be evaluated.
Helius Medical Technologies's "short interest ratio" (SIR) is the quantity of Helius Medical Technologies shares currently shorted divided by the average quantity of Helius Medical Technologies shares traded daily (recently around 166845.21575985). Helius Medical Technologies's SIR currently stands at 5.33. In other words for every 100,000 Helius Medical Technologies shares traded daily on the market, roughly 5330 shares are currently held short.
However Helius Medical Technologies's short interest can also be evaluated against the total number of Helius Medical Technologies shares, or, against the total number of tradable Helius Medical Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Helius Medical Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Helius Medical Technologies shares in existence, roughly 20 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Helius Medical Technologies shares, roughly 19 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Helius Medical Technologies.
Find out more about how you can short Helius Medical Technologies stock.
We're not expecting Helius Medical Technologies to pay a dividend over the next 12 months.
Helius Medical Technologies's shares were split on a 1:5 basis on 23 January 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Helius Medical Technologies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Helius Medical Technologies shares which in turn could have impacted Helius Medical Technologies's share price.
Over the last 12 months, Helius Medical Technologies's shares have ranged in value from as little as $0.249 up to $1.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Helius Medical Technologies's is 0.7706. This would suggest that Helius Medical Technologies's shares are less volatile than average (for this exchange).
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
Everything we know about the Bakkt Holdings IPO, plus information on how to buy in.
Everything we know about the Dream Finders Homes Inc IPO, plus information on how to buy in.
Everything we know about the Q BioMed Inc IPO, plus information on how to buy in.
Everything we know about the Faraday Future IPO, plus information on how to buy in.
Everything we know about the TELUS International Inc IPO, plus information on how to buy in.
Everything we know about the Interior Logic Group Holdings LLC IPO, plus information on how to buy in.
Everything we know about the Evaxion Biotech IPO, plus information on how to buy in.
Everything we know about the ON24 Inc IPO, plus information on how to buy in.
Everything we know about the Home Point Capital Inc IPO, plus information on how to buy in.
Everything we know about the ALFI INC IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.